RE:RE:RE:RE:RE:Huge Global Blood Cancer MarketComplexity of the procedure??? Seems pretty straight forward to me. My jaded opinion is we don't have the $ to grease the PI's to promote our trial over the Big Pharma trials. I would love to be a fly on the wall when Doc's are discussing trial options with patients.
This should be the way it goes - Hey patient you can go with the Big pharma option with its 20 or more treatments and countless side effects and inferior efficacy or you can go with the one or 2 treatment, no side effects and improving efficacy with TLT. Which one would you like to sign up for?
If that was the the way it was presented, you would think we would be done already. Yet here we are struggling to find patients. Doesn't make sense.